<DOC>
	<DOCNO>NCT01532180</DOCNO>
	<brief_summary>The objective study determine safety preliminary efficacy patient utilize aura6000 System treatment Obstructive Sleep Apnea ( OSA ) .</brief_summary>
	<brief_title>Safety Efficacy Hypoglossal Nerve Implant Treatment Obstructive Sleep Apnea ( OSA )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Signs Symptoms</mesh_term>
	<mesh_term>Respiration Disorders</mesh_term>
	<mesh_term>Signs Symptoms , Respiratory</mesh_term>
	<criteria>Moderate severe obstructive sleep apnea ( AHI 15 60 ) . Can tolerate CPAP treatment . Body mass index ( BMI ) 25 40 Able read , understand , sign date write informed consent form</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Obstructive sleep apnea , neurostimulation , hypoglossal nerve</keyword>
</DOC>